BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 15779302)

  • 1. [Problems with the ASCUS (atypical squamous cells of undetermined significance) in the Bethesda system].
    Nyklícek O
    Ceska Gynekol; 2005 Jan; 70(1):86-8. PubMed ID: 15779302
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controversial categories in cytopathology of the uterine cervix. I. ASCUS: atypical squamous cells of undetermined significance].
    Cenci M; Chieppa A; Vecchione A
    Minerva Ginecol; 2001 Feb; 53(1):49-55. PubMed ID: 11279396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical squamous and glandular cells of undetermined significance (ASCUS and AGUS) of the uterine cervix.
    Cenci M; Vecchione A
    Anticancer Res; 2000; 20(5C):3701-7. PubMed ID: 11268442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion.
    Gonzalez D; Hernandez E; Anderson L; Heller P; Atkinson BF
    J Reprod Med; 1996 Oct; 41(10):719-23. PubMed ID: 9026557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical squamous cells of undetermined significance qualified: a follow-up study.
    Kline MJ; Davey DD
    Diagn Cytopathol; 1996 Jun; 14(4):380-4. PubMed ID: 8725142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
    Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
    Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical squamous cells of undetermined significance. Current laboratory practices of participants in the College of American Pathologists Interlaboratory. Comparison Program in Cervicovaginal Cytology.
    Davey DD; Nielsen ML; Naryshkin S; Robb JA; Cohen T; Kline TS
    Arch Pathol Lab Med; 1996 May; 120(5):440-4. PubMed ID: 8639046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of human papillomavirus test in triage of patients with atypical squamous cell of undetermined significance].
    Zhao J; Zhou JN; Yang YJ; Liao QP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):299-301. PubMed ID: 19105350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ASCUS: an update].
    Boulanger JC; Sevestre H
    Gynecol Obstet Fertil; 2006 Jan; 34(1):44-8. PubMed ID: 16406731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytology.
    Sherman ME; Dasgupta A; Schiffman M; Nayar R; Solomon D
    Cancer; 2007 Feb; 111(1):15-25. PubMed ID: 17186503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses.
    Sherman ME; Schiffman MH; Erozan YS; Wacholder S; Kurman RJ
    Arch Pathol Lab Med; 1992 Nov; 116(11):1155-8. PubMed ID: 1444745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed Sheffield quantitative criteria in cervical cytology to assist the diagnosis and grading of squamous intra-epithelial lesions, as some Bethesda system definitions require amendment.
    Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH
    Cytopathology; 2005 Aug; 16(4):168-78. PubMed ID: 16048503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Educational needs and causes of false diagnosis of atypical squamous cells of unknown significance at a university hospital.
    Kumar N; Sayed S; Moloo Z
    Afr J Reprod Health; 2011 Mar; 15(1):113-6. PubMed ID: 21987946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Applicative aspects of liquid-based cytology in cervical cancer screening].
    Liverani M; De Paola F; Danesi S; Fedriga R; Dalbuoni V; Agnoletti R; Amadori AR; Mirra F; Bonoli W; Saragoni L
    Pathologica; 2006 Dec; 98(6):629-34. PubMed ID: 17285839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colposcopic and histologic findings in women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
    Yarandi F; Izadi Mood N; Mirashrafi F; Eftekhar Z
    Aust N Z J Obstet Gynaecol; 2004 Dec; 44(6):514-6. PubMed ID: 15598287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes.
    Musa J; Taiwo B; Goldsmith S; Sutton S; Berzins B; Murphy RL
    Arch Gynecol Obstet; 2011 Feb; 283(2):343-8. PubMed ID: 20229315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Support from authors of the Bethesda system.
    Nayar R; Solomon D
    Cytopathology; 2008 Dec; 19(6):399-400. PubMed ID: 19040548
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis of cervical neoplasm--cytology].
    Nishikawa A
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():113-8. PubMed ID: 15535217
    [No Abstract]   [Full Text] [Related]  

  • 20. Problems encountered with the Bethesda System: the University of Iowa experience.
    Bottles K; Reiter RC; Steiner AL; Zaleski S; Bedrossian CW; Johnson SR
    Obstet Gynecol; 1991 Sep; 78(3 Pt 1):410-4. PubMed ID: 1876375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.